Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans

Size: px
Start display at page:

Download "Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans"

Transcription

1 Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans Schwaiger Julia Clinical Institute of Virology

2 Thank you! Franz X. Heinz Judith Aberle all my colleagues: 2

3 Background 3

4 Flaviviruses - Serocomplexes 4 Fields Virology 4th ed.

5 Flaviviruses - Genome 5 Fields Virology 5th ed.

6 TBE - occurence 6

7 Antigen presentation 7

8 MHC restriction and epitope immunodominance Association between HLA haplotype and disease expression (DEN, Hep B, CMV) 8

9 MHC restriction and epitope immunodominance Association between HLA haplotype and disease expression (DEN, Hep B, CMV) Only very few of theoretical possible peptides lead to an immune response 9

10 MHC restriction and epitope immunodominance Association between HLA haplotype and disease expression (DEN, Hep B, CMV) Only very few of theoretical possible peptides lead to an immune response Immunodominance 10

11 MHC restriction and epitope immunodominance Association between HLA haplotype and disease expression (DEN, Hep B, CMV) Only very few of theoretical possible peptides lead to an immune response Immunodominance T-cell specificity is important for the course of illness (HCV, HIV) CD4 epitope pattern is important in the immune response to viral infection 11

12 T-cell response to flaviviruses Dengue virus West Nile virus Japanese encephalitis virus Kunjin virus Murray valley encephalitis virus 12 Fields Virology 5th ed.

13 Objectives Aims 13

14 Objectives Comparison of TBEV epitope specificity, functionality and breadth in TBEV infection versus TBE vaccination in humans. 14

15 4 aims: Establish a sensitive IFN-γ ELISpot assay Identify TBEV-specific T-cell targets in natural TBEV infection and TBEV vaccination Effector phase Memory phase Characterization of phenotype and function of TBEV eptiope-specific T-cells Analyse whether age is associated with a decline in the T-cell response pattern 15

16 Patients Methods 16

17 Patients 80 patients 40 TBEV infected patients * 40 TBE vaccinated patients 20 >50 years 20 <30 years 20 >50 years 20 <30 years * patients with acute TBEV infection (recruited in Budweis) probands with regular TBE vaccination after booster vaccination (recruited in Vienna) 17

18 Patients TBEV infected patients TBE vaccinated patients 18

19 IFN-γ ELISpot Isolation of monocytes from PBMC by MACS Preparation of immature dendritic cells (idc) IFN-γ ELISpot 19

20 FACS CD4+ CD3 gated cells: (to exclude NK cells) CD4 CD8+ IFN-γ 20

21 Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans Establishing a highly sensitive IFN-γ ELISpot assay 9 8 E-50 number of responders E-4 E-12 2 E-3 E-37E-41 E E-1 E-6 E-11 E-16 E-21 E-26 E-31 E-36 E-41 E-46 E-51 E-56 E-61 E-66 E-71 E-76 E-81 E-86 E-91 overlapping peptides Identifying TBEV-specific T-cell targets after infection and vaccination Characterizing the phenotypical and functional properties of TBEV epitope-specific T-cells Age => decline in the T-cell response pattern? 21

22 22

23 References (1) Paradoa Perez ML, Trujillo Y, Basanta P. Association of dengue hemorrhagic fever with the HLA system. Haematologia (Budap) 1987; 20(2):83-7. (2) Lan NT, Kikuchi M, Huong VT, et al. Protective and Enhancing HLA Alleles, HLA-DRB1*0901 and HLA-A*24, for Severe Forms of Dengue Virus Infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome. PLoS Negl Trop Dis 2008; 2(10):e304. (3) Huang YW, Hu CY, Chen CL, et al. Human leukocyte antigen-drb1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus. J Med Virol 2009; 81(4): (4) Varga M, Rajczy K, Telkes G, et al. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients. Nephrol Dial Transplant 2008; 23(8): (5) Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77(3): (6) Schulze zur Wiesch J, Lauer GM, Day CL, et al. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 2005; 175(6): (7) Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194(10): (8) Parsons R, Lelic A, Hayes L, et al. The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes. J Immunol 2008; 181(2): (9) Simmons CP, Dong T, Chau NV, et al. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol 2005; 79(9): (10) Kumar P, Krishna VD, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J Gen Virol 2004; 85(Pt 2): (11) Hill AB, Mullbacher A, Parrish C, Coia G, Westaway EG, Blanden RV. Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses. J Gen Virol 1992; 73 ( Pt 5): (12) Lobigs M, Arthur CE, Mullbacher A, Blanden RV. The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology 1994; 202(1):

24 IFN-γ ELISpot 24 Sigma-Aldrich, online

25 IFN-γ ELISpot 25

Identification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods

Identification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES PKS Chan 陳 基 湘 S Ma 文 子 光 SM Ngai 倪 世 明 Key Messages 1. Subjects recovered from SARS-CoV infection retain memory of cellular immune response to epitopes

More information

Analysis of the adaptive immune response to West Nile virus

Analysis of the adaptive immune response to West Nile virus Analysis of the adaptive immune response to West Nile virus Jonathan Bramson (PI) Robin Parsons Alina Lelic Galina Denisova Lesley Latham Carole Evelegh Dmitri Denisov Strategy for characterizing T cell

More information

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia Pathogenesis of Dengue Natalia Taborda Vanegas Doc. Sci. Student Immunovirology Group Universidad de Antioquia Infection process Epidermis keratinocytes Dermis Archives of Medical Research 36 (2005) 425

More information

A white paper for consideration by the NIAID Microbial Sequencing Program

A white paper for consideration by the NIAID Microbial Sequencing Program Hepatitis C Virus Sequencing: Viral evolution, immune recognition and vaccine development. A white paper for consideration by the NIAID Microbial Sequencing Program Todd M. Allen, Ph.D. Assistant Professor

More information

Table S4. NS3 T cell epitopes found in the literature. A) T helper epitopes

Table S4. NS3 T cell epitopes found in the literature. A) T helper epitopes Table S4. NS3 T cell epitopes found in the literature A) T helper epitopes Epitope Protein Position Genotype MHC II Association Reference TRTIASPKGPVIQMY NS3 1087-1101 1A class II (4) DLVGWPAPQGSRSLT NS3

More information

Assays to evaluate cell-mediated immunity. Guus Rimmelzwaan Department of Virology Erasmus Medical Center Rotterdam The Netherlands

Assays to evaluate cell-mediated immunity. Guus Rimmelzwaan Department of Virology Erasmus Medical Center Rotterdam The Netherlands Assays to evaluate cell-mediated immunity Guus Rimmelzwaan Department of Virology Erasmus Medical Center Rotterdam The Netherlands CBER/NIAID/WHO, Bethesda MD, December 11 2007 A working model of an antiviral

More information

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015 The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response

More information

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS Prospects for Vaccines against Hepatitis C Viruses T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS HCV Vaccine Prevention strategies Protective immunity Barriers and solutions Vaccine candidates

More information

Modelling and analysis of T-cell epitope screening data.

Modelling and analysis of T-cell epitope screening data. Modelling and analysis of T-cell epitope screening data. Tim Beißbarth 2, Jason A. Tye-Din 1, Gordon K. Smyth 1, Robert P. Anderson 1 and Terence P. Speed 1 1 WEHI, 1G Royal Parade, Parkville, VIC 3050,

More information

02/08/2010. 1. Background. Outline

02/08/2010. 1. Background. Outline Identification of immunodominant T-cell eptitopes in matrix protein of highly pathogenic porcine reproductive and respiratory syndrome virus Ya-Xin Wang, PhD Student Outline 1. Background 2. Research Contents

More information

Hepatitis C Vaccines: Are we making progress?

Hepatitis C Vaccines: Are we making progress? Hepatitis C Vaccines: Are we making progress? Second International Hepatitis Cure and Eradication Meeting. Vancouver November, 2015 Objectives: Review the need for a preventive vaccine in 2015. Identify

More information

Chapter 43: The Immune System

Chapter 43: The Immune System Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2

More information

Diagnosing arbovirus infections (and Bill s holiday snaps) David W Smith Division of Microbiology and Infectious Diseases PathCentre

Diagnosing arbovirus infections (and Bill s holiday snaps) David W Smith Division of Microbiology and Infectious Diseases PathCentre Diagnosing arbovirus infections (and Bill s holiday snaps) David W Smith Division of Microbiology and Infectious Diseases PathCentre Arboviral illnesses relevant to Australia Polyarthralgia Fever and rash

More information

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes

More information

THE INFLUENCE OF TISSUE (IN)COMPATIBILITY IN UMBILICAL CORD BLOOD TRANSPLANTATION

THE INFLUENCE OF TISSUE (IN)COMPATIBILITY IN UMBILICAL CORD BLOOD TRANSPLANTATION THE INFLUENCE OF TISSUE (IN)COMPATIBILITY IN UMBILICAL CORD BLOOD TRANSPLANTATION Matjaž Jeras Blood Transfusion Centre of Slovenia Tissue Typing Center Šlajmerjeva 6, 1000 Ljubljana, Slovenia matjaz.jeras@ztm.si

More information

Altered Cytokine Responses of Dengue-Specific CD4 T Cells to Heterologous Serotypes 1

Altered Cytokine Responses of Dengue-Specific CD4 T Cells to Heterologous Serotypes 1 Altered Cytokine Responses of Dengue-Specific CD4 T Cells to Heterologous Serotypes 1 Maloy M. Mangada 2 and Alan L. Rothman The interplay of different inflammatory cytokines induced during a dengue (DEN)

More information

International Journal of Integrative Biology A journal for biology beyond borders ISSN 0973-8363

International Journal of Integrative Biology A journal for biology beyond borders ISSN 0973-8363 Report International Journal of Integrative Biology A journal for biology beyond borders ISSN 0973-8363 In silico CD4+ T cell epitope mapping and HLA coverage analysis for proteins of human hepatitis E

More information

Early HIV- specific CD8 + T cell responses in treated and untreated hyper acute HIV infec=on in the FRESH cohort

Early HIV- specific CD8 + T cell responses in treated and untreated hyper acute HIV infec=on in the FRESH cohort Early HIV- specific CD8 + T cell responses in treated and untreated hyper acute HIV infec=on in the FRESH cohort Zaza M&ne Ndhlovu, PhD Instructor in Medicine Ragon Ins&tute of MGH, MIT and Harvard Senior

More information

DEPARTMENT OF IMMUNOLOGY Chair of Histology and Immunology Medical University of Gdańsk

DEPARTMENT OF IMMUNOLOGY Chair of Histology and Immunology Medical University of Gdańsk DEPARTMENT OF IMMUNOLOGY Chair of Histology and Immunology Medical University of Gdańsk Research group Head: Jolanta Myśliwska, MD, PhD Professor of immunology Joanna Więckiewicz, M. Sc. Dominik Rachoń,

More information

Curriculum Vitae. Peter Graves Livingston M.D. EDUCATION: CERTIFICATIONS and HONORS:

Curriculum Vitae. Peter Graves Livingston M.D. EDUCATION: CERTIFICATIONS and HONORS: Curriculum Vitae Peter Graves Livingston M.D. Birthplace: Boston, Massachusetts Medical License: Florida ME 102736 Work Address: Macula and Diabetic Eye Center, LLC 4916 26 th Street West, Suite 200 Bradenton,

More information

DNA Vaccine for Chronic Hepatitis C

DNA Vaccine for Chronic Hepatitis C Novel Vaccine Development (3:00PM~3:30PM) DNA Vaccine for Chronic Hepatitis C : Preclinical Evaluation of Immunogenicity and Safety of VGX-6150 Moonsup JEONG, Ph.D. Director of Pharma R&D Division GeneOne

More information

PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands

PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands W138 W142 doi:10.1093/nar/gki357 PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands Pedro A. Reche 1,2, * and Ellis L. Reinherz 1,2 1 Laboratory

More information

Identification of CD8 + T Cell Epitopes in the West Nile Virus Polyprotein by Reverse-Immunology Using NetCTL

Identification of CD8 + T Cell Epitopes in the West Nile Virus Polyprotein by Reverse-Immunology Using NetCTL Identification of CD8 + T Cell Epitopes in the West Nile Virus Polyprotein by Reverse-Immunology Using NetCTL Mette Voldby Larsen 1 *, Alina Lelic 2, Robin Parsons 2, Morten Nielsen 1, Ilka Hoof 1, Kasper

More information

Anti-CD38 anti-cd3 bispecific antibody in multiple myeloma

Anti-CD38 anti-cd3 bispecific antibody in multiple myeloma Anti-CD38 anti-cd3 bispecific antibody in multiple myeloma David E. Szymkowski Senior Director, Biotherapeutics Proteins by Design 1960s...1980s...2000s... Where are the bispecific antibody drugs? J Exp.

More information

New developments in antigen-specific immunotherapies Novel therapeutic vaccines offer hope in the fight against chronic infectious disease and cancer

New developments in antigen-specific immunotherapies Novel therapeutic vaccines offer hope in the fight against chronic infectious disease and cancer New developments in antigen-specific immunotherapies Novel therapeutic vaccines offer hope in the fight against chronic infectious disease and cancer Vaccination has been used effectively for more than

More information

Cytotoxic T lymphocytes and natural killer cells

Cytotoxic T lymphocytes and natural killer cells Cytotoxic T lymphocytes and natural killer cells Margrit Wiesendanger Division of General Medicine, CUMC September 16, 2009 Killer cells: CD8 + T cells (adaptive) vs. natural killer (innate) Shared purpose:

More information

Downloaded from: http://researchonline.lshtm.ac.uk/19718/

Downloaded from: http://researchonline.lshtm.ac.uk/19718/ Dockrell, H M; Brahmbhatt, S; Robertson, B D; Britton, S; Fruth, U; Gebre, N; Hunegnaw, M; Hussain, R; Manadhar, R; Murrillo, L; Pessolani, M C; Roche, P; Salgado, J L; Sampaio, E; Shahid, F; Thole, J

More information

With a staggering one billion individuals worldwide

With a staggering one billion individuals worldwide Immunology and Microbiology A Herpes Simplex Virus Type 1 Human Asymptomatic CD8 þ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a Humanized HLA Transgenic Rabbit Model Ruchi Srivastava,

More information

CHAPTER 8 IMMUNOLOGICAL IMPLICATIONS OF PEPTIDE CARBOHYDRATE MIMICRY

CHAPTER 8 IMMUNOLOGICAL IMPLICATIONS OF PEPTIDE CARBOHYDRATE MIMICRY CHAPTER 8 IMMUNOLOGICAL IMPLICATIONS OF PEPTIDE CARBOHYDRATE MIMICRY Immunological Implications of Peptide-Carbohydrate Mimicry 8.1 Introduction The two chemically dissimilar molecules, a peptide (12mer)

More information

Detection of T-cell T and their application to vaccine design

Detection of T-cell T and their application to vaccine design QuickTime and a TIFF (Uncompressed) decompressor are needed to see this picture Detection of T-cell T epitopes and their application to vaccine design EpiVax Inc. 16 Bassett Street Providence Rhode Island

More information

PEPVAC: A web server for multi-epitope vaccine development based on the prediction of supertypic

PEPVAC: A web server for multi-epitope vaccine development based on the prediction of supertypic PEPVAC: A web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands Pedro A. Reche and Ellis L. Reinherz Laboratory of Immunobiology and Department of Medical Oncology,

More information

Etiology of Type 1 Diabetes Chris Theberge

Etiology of Type 1 Diabetes Chris Theberge Etiology of Type 1 Diabetes Chris Theberge Type 1 diabetes, or Insulin Dependent Diabetes Mellitus (IDDM), is a disease characterized by auto-destruction of the pancreatic beta cells that produce insulin.

More information

TOWARDS AN HIV VACCINE

TOWARDS AN HIV VACCINE why is it so hard to make an HIV vaccine and where are we now? Neal Nathanson, MD Emeritus Professor Department of Microbiology University of Pennsylvania School of Medicine 1 Estimated number of persons

More information

Appendix B: Provincial Case Definitions for Reportable Diseases

Appendix B: Provincial Case Definitions for Reportable Diseases Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: West Nile Virus Illness Revised December 2014 West Nile Virus Illness 1.0 Provincial Reporting Confirmed

More information

TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS

TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS Karine Lélu 1, Alexei Evlachev 1, Roland Kratzer 1, Sarah

More information

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School

More information

BioMmune Technologies Inc. Corporate Presentation 2015

BioMmune Technologies Inc. Corporate Presentation 2015 BioMmune Technologies Inc Corporate Presentation 2015 * Harnessing the body s own immune system to fight cancer & other autoimmune diseases BioMmune Technologies Inc. (IMU) ABOUT A public biopharmaceutical

More information

AAB 2013 Annual Meeting & Educational Conference

AAB 2013 Annual Meeting & Educational Conference American Association of Bioanalysts AAB 2013 Annual Meeting & Educational Conference Occult Hepatitis and HIV Prophylaxis Thursday, May 16, 2013, 9:45 a.m. John H. Hughes, Ph.D. Dept Molecular Virology,

More information

Core Topic 2. The immune system and how vaccines work

Core Topic 2. The immune system and how vaccines work Core Topic 2 The immune system and how vaccines work Learning outcome To be able to describe in outline the immune system and how vaccines work in individuals and populations Learning objectives Explain

More information

Prediction of T cell epitopes for the utility of vaccine development from structural proteins of dengue virus variants using in silico methods

Prediction of T cell epitopes for the utility of vaccine development from structural proteins of dengue virus variants using in silico methods Indian Journal of Biotechnology Vol 8, April 2009, pp 193-198 Prediction of T cell epitopes for the utility of vaccine development from structural proteins of dengue virus variants using in silico methods

More information

TRANSGENE SA, FRANCE 2. INSTITUT PASTEUR, FRANCE On behalf. AFEF 2013, Lille 02 nd October 2013

TRANSGENE SA, FRANCE 2. INSTITUT PASTEUR, FRANCE On behalf. AFEF 2013, Lille 02 nd October 2013 A MULTIVALENT ADENOVIRUS-BASED IMMUNOTHERAPEUTIC FOR TREATMENT OF CHRONIC HEPATITIS B INDUCES BROAD, ROBUST AND POLYFUNCTIONAL T CELLS IN NAIVE MICE AND EXERT AN EARLY ANTIVIRAL EFFECT IN HBV TOLERANT

More information

Why use passive immunity?

Why use passive immunity? Vaccines Active vs Passive Immunization Active is longer acting and makes memory and effector cells Passive is shorter acting, no memory and no effector cells Both can be obtained through natural processes:

More information

III III a IIOI OlD III OlD IIO 1101 010 III DID III 100 III0 II uii IIi

III III a IIOI OlD III OlD IIO 1101 010 III DID III 100 III0 II uii IIi III III a IIOI OlD III OlD IIO 1101 010 III DID III 100 III0 II uii IIi US oi ^^_._.,o.i ^,) United States (12) Patent Application Publication Buyse et al. (43) Pub. Date: Oct. 28, (54) HPV POLYEPITOPE

More information

The autophagy machinery is required to initiate hepatitis C virus infection. Marlène Dreux

The autophagy machinery is required to initiate hepatitis C virus infection. Marlène Dreux The autophagy machinery is required to initiate hepatitis C virus infection Marlène Dreux Hepatitis C virus life cycle HCV particles internalization RNA replication RNA translation ER HCV assembly and

More information

Severe Combined Immune Deficiency (SCID)

Severe Combined Immune Deficiency (SCID) Severe Combined Immune Deficiency (SCID) ASCIA EDUCATION RESOURCES (AER) PATIENT INFORMATION Severe combined immune deficiency (SCID) is the most serious form of primary immune deficiency and is usually

More information

What Shots Do I Need? Stan Houston MD DTM&H FRCPC Department of Medicine & School of Public Health Consultant, Travellers Health Service

What Shots Do I Need? Stan Houston MD DTM&H FRCPC Department of Medicine & School of Public Health Consultant, Travellers Health Service What Shots Do I Need? Stan Houston MD DTM&H FRCPC Department of Medicine & School of Public Health Consultant, Travellers Health Service Faculty /Presenter Disclosure Faculty: Stan Houston Relationships

More information

Microbiology AN INTRODUCTION EIGHTH EDITION

Microbiology AN INTRODUCTION EIGHTH EDITION TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein

More information

Potency Assays for an Autologous Active Immunotherapy (Sipuleucel-T) Pocheng Liu, Ph.D. Senior Scientist of Product Development Dendreon Corporation

Potency Assays for an Autologous Active Immunotherapy (Sipuleucel-T) Pocheng Liu, Ph.D. Senior Scientist of Product Development Dendreon Corporation Potency Assays for an Autologous Active Immunotherapy (Sipuleucel-T) Pocheng Liu, Ph.D. Senior Scientist of Product Development Dendreon Corporation Sipuleucel-T Manufacturing Process Day 1 Leukapheresis

More information

Understanding West Nile Virus Infection

Understanding West Nile Virus Infection Understanding West Nile Virus Infection The QIAGEN Bioinformatics Solution: Biomedical Genomics Workbench (BXWB) + Ingenuity Pathway Analysis (IPA) Functional Genomics & Predictive Medicine, May 21-22,

More information

HemaCare Corporation Company Overview. Comprehensive Product and Service Solutions for BioResearch and Cellular Therapy

HemaCare Corporation Company Overview. Comprehensive Product and Service Solutions for BioResearch and Cellular Therapy HemaCare Corporation Company Overview Comprehensive Product and Service Solutions for BioResearch and Cellular Therapy 2015 HemaCare Corporation Leading provider of apheresis products, human blood cells,

More information

IDENTIFICATION OF T-CELL ANTIGENIC DETERMINANTS IN THE PROTEINS OF HUMAN PAPILLOMAVIRUS

IDENTIFICATION OF T-CELL ANTIGENIC DETERMINANTS IN THE PROTEINS OF HUMAN PAPILLOMAVIRUS INTERNATIONAL JOURNAL OF ADVANCED BIOTECHNOLOGY AND BIOINFORMATICS VOL.1, ISSUE.1, November 2012 IDENTIFICATION OF T-CELL ANTIGENIC DETERMINANTS IN THE PROTEINS OF HUMAN PAPILLOMAVIRUS ABSTRACT Dharmendra

More information

Human Leukocyte Antigens - HLA

Human Leukocyte Antigens - HLA Human Leukocyte Antigens - HLA Human Leukocyte Antigens (HLA) are cell surface proteins involved in immune function. HLA molecules present antigenic peptides to generate immune defense reactions. HLA-class

More information

Name (print) Name (signature) Period. (Total 30 points)

Name (print) Name (signature) Period. (Total 30 points) AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,

More information

Reconsideration Code 86386. Reconsideration Code Description Nuclear Matrix Protein 22 (NMP22), qualitative

Reconsideration Code 86386. Reconsideration Code Description Nuclear Matrix Protein 22 (NMP22), qualitative Calendar Year 2013 Centers for Medicare and Medicaid Services (CMS) New and Reconsidered Clinical Laboratory Fee Schedule (CLFS) Test Codes And Final Payment Determinations Reconsideration Code 86386 Reconsideration

More information

Algorithm for detecting Zika virus (ZIKV) 1

Algorithm for detecting Zika virus (ZIKV) 1 Algorithm for detecting Zika virus (ZIKV) 1 This algorithm is addressed to laboratories with established capacity (molecular, antigenic and/or serological) to detect dengue (DENV), Zika (ZIKV) 2, and chikungunya

More information

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC HIV What are HIV and AIDS? HIV stands for Human Immunodeficiency Virus. This is the virus that causes AIDS. HIV is

More information

Rheumatoid arthritis: an overview. Christine Pham MD

Rheumatoid arthritis: an overview. Christine Pham MD Rheumatoid arthritis: an overview Christine Pham MD RA prevalence Chronic inflammatory disease affecting approximately 0.5 1% of the general population Prevalence is higher in North America (approaching

More information

CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma

CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma Occult HBV Infection: Assessment and Clinical Significance D. Lorne Tyrrell Director, Li Ka Shing Institute of Virology University of Alberta

More information

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION

More information

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several

More information

Medical publications on HBV and HCV Coinfection

Medical publications on HBV and HCV Coinfection Recent advances of HBV and HCV co-infection 台 中 榮 總 內 科 部 胃 腸 肝 膽 科 呂 宜 達 醫 師 2013.03.28 Outline Epidemiology of HBV and HCV coinfection Clinical significance of HBV and HCV coinfection Interplay between

More information

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer

More information

Why study T cell epitopes in allergic disease?

Why study T cell epitopes in allergic disease? Why study T cell epitopes in allergic disease? T cells contribute to pathology directly and indirectly through modulation of immune responses Involvement in SIT Epitopes as a tool to monitor disease and

More information

Immunity Unit Test Z

Immunity Unit Test Z Immunity Unit Test Z Name MB Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Which of the pathogens in Figure 31.1 cause disease by taking over healthy

More information

Immune Epitope Database NEWSLETTER Volume 7, Issue 1 http://www.iedb.org March 2010

Immune Epitope Database NEWSLETTER Volume 7, Issue 1 http://www.iedb.org March 2010 Immune Epitope Database NEWSLETTER Volume 7, Issue 1 http://www.iedb.org March 2010 IEBD 2.3 Released January 19 The latest version of the IEDB website was released on January 19. A list of the new features

More information

T Cell Maturation,Activation and Differentiation

T Cell Maturation,Activation and Differentiation T Cell Maturation,Activation and Differentiation Positive Selection- In thymus, permits survival of only those T cells whose TCRs recognize self- MHC molecules (self-mhc restriction) Negative Selection-

More information

Identification of Dengue-specific B-Cell Epitopes by Phage-display Random Peptide Library

Identification of Dengue-specific B-Cell Epitopes by Phage-display Random Peptide Library Malaysian Journal of Medical Sciences, Vol. 16, No. 4, Pg 4-14, October - December 2009 Original Article Identification of Dengue-specific B-Cell Epitopes by Phage-display Random Peptide Library Nevis

More information

Cytoreductive Therapy for Autologous Cell Therapy in HIV

Cytoreductive Therapy for Autologous Cell Therapy in HIV Cytoreductive Therapy for Autologous Cell Therapy in HIV Ronald Mitsuyasu, MD Professor of Medicine UCLA Center for Clinical AIDS Research and Education (CARE Center) HSC Transfer from CCR5-delta 32 Donor

More information

International Symposium on Malignant Mesothelioma 2011 -- curemeso.org

International Symposium on Malignant Mesothelioma 2011 -- curemeso.org Measles virotherapy for malignant mesothelioma Manish R. Patel, D.O. Assistant Professor of Medicine University of Minnesota June 25, 2011 Medical Treatment of Mesothelioma Majority of patients are not

More information

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

Hapten - a small molecule that is antigenic but not (by itself) immunogenic. Chapter 3. Antigens Terminology: Antigen: Substances that can be recognized by the surface antibody (B cells) or by the TCR (T cells) when associated with MHC molecules Immunogenicity VS Antigenicity:

More information

The Costimulatory Molecule CD27 Maintains Clonally

The Costimulatory Molecule CD27 Maintains Clonally Immunity, Volume 35 Supplemental Information The Costimulatory Molecule CD7 Maintains Clonally Diverse CD8 + T Cell Responses of Low Antigen Affinity to Protect against Viral Variants Klaas P.J.M. van

More information

New HLA class I epitopes defined by murine monoclonal antibodies

New HLA class I epitopes defined by murine monoclonal antibodies Human Immunology 71 (2010) 456 461 Contents lists available at ScienceDirect New HLA class I epitopes defined by murine monoclonal antibodies Nadim El-Awar a, *, Paul I. Terasaki b, Anh Nguyen a, Mamie

More information

BioResearch. Hematopoietic and Immune Cell Products Essential Tools for Hematopoietic Research

BioResearch. Hematopoietic and Immune Cell Products Essential Tools for Hematopoietic Research BioResearch Hematopoietic and Immune Cell Products Essential Tools for Hematopoietic Research BioResearch Hematopoietic and Immune Cell Products Essential Tools for Hematopoietic Research Working with

More information

HIV and Autoimmune Disease - The Cure Research

HIV and Autoimmune Disease - The Cure Research 1. Purpose of the study- This is a cross-sectional study that analyzes the sera of subjects in order to answer two clinical questions. First, we will assay the antibody profiles of subjects with autoimmune

More information

The Body s Defenses CHAPTER 24

The Body s Defenses CHAPTER 24 CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,

More information

Immunity and how vaccines work

Immunity and how vaccines work 1 Introduction Immunity is the ability of the human body to protect itself from infectious disease. The defence mechanisms of the body are complex and include innate (non-specific, non-adaptive) mechanisms

More information

B D B D 3 PCR-RFLP T/T B B. Occult HBV Infection (OBI) B. HBsAg. e-mail: kazemi24@yahoo.com

B D B D 3 PCR-RFLP T/T B B. Occult HBV Infection (OBI) B. HBsAg. e-mail: kazemi24@yahoo.com 3 anti-hc HsAg HV- anti-hc HsAg TT anti-hc HV- anti-hc t/t HsAg HV- -RFLP Occult HV Infection (OI) HV- HsAg HsAg e-mail: kazemi24@yahoo.com HsAg (RAIM, Italy) anti-hc anti-hiv anti-hcv clearance ehring,

More information

The donor search: the best donor or cord blood unit

The donor search: the best donor or cord blood unit The donor search: the best donor or cord blood unit Dr Bronwen Shaw Consultant in haematopoietic cell transplantation Royal Marsden Hospital /Anthony Nolan Overview Where do we find donors/units for transplantation

More information

APPLICATION SUMMER MEDICAL IMMUNOLOGY COURSE SUMMER MEDICAL MICROBIOLOGY COURSE RUSH MEDICAL COLLEGE. NAME: (Last) (First) (Middle Initial)

APPLICATION SUMMER MEDICAL IMMUNOLOGY COURSE SUMMER MEDICAL MICROBIOLOGY COURSE RUSH MEDICAL COLLEGE. NAME: (Last) (First) (Middle Initial) APPLICATION SUMMER MEDICAL IMMUNOLOGY COURSE SUMMER MEDICAL MICROBIOLOGY COURSE RUSH MEDICAL COLLEGE NAME: (Last) (First) (Middle Initial) E-Mail: Gender: / /Male / /Female Date of Birth: / / - / / -/

More information

The Epidemiology of Hepatitis A, B, and C

The Epidemiology of Hepatitis A, B, and C The Epidemiology of Hepatitis A, B, and C Jamie Berkes M.D. University of Illinois at Chicago jberkes@uic.edu Epidemiology: Definitions The study of the incidence and prevalence of diseases in large populations

More information

Multiple Choice Questions

Multiple Choice Questions C hapter 13 WHY DO WE FALL ILL Multiple Choice Questions 1. Which one of the following is not a viral disease? (a) Dengue (b) AIDS (c) Typhoid (d) Influenza 2. Which one of the following is not a bacterial

More information

Mouse IFN-gamma ELISpot Kit

Mouse IFN-gamma ELISpot Kit Page 1 of 8 Mouse IFN-gamma ELISpot Kit Without Plates With Plates With Sterile Plates Quantity Catalog Nos. 862.031.001 862.031.001P 862.031.001S 1 x 96 tests 862.031.005 862.031.005P 862.031.005S 5 x

More information

Case Finding for Hepatitis B and Hepatitis C

Case Finding for Hepatitis B and Hepatitis C Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center

More information

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE DISEASE 101 ONLINE CONFERENCE SARAH WENINGER, MPH VIRAL HEPATITIS.STD.HIV PREVENTION COORDINATOR DECEMBER 3, 2015 OBJECTIVES Describe the populations that should

More information

Title: Mapping T cell epitopes in PCV2 capsid protein - NPB #08-159. Date Submitted: 12-11-09

Title: Mapping T cell epitopes in PCV2 capsid protein - NPB #08-159. Date Submitted: 12-11-09 Title: Mapping T cell epitopes in PCV2 capsid protein - NPB #08-159 Investigator: Institution: Carol Wyatt Kansas State University Date Submitted: 12-11-09 Industry summary: Effective circovirus vaccines

More information

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection Module 1 Overview of HIV Infection Purpose Pre-requisite Modules Learning Objectives To provide you with the basic terms and concepts related to HIV infection. None At the end of this module, you will

More information

Report of Independent Certified Public Accountants in Accordance with OMB Circular A-133. Blood Systems, Inc. and Affiliates.

Report of Independent Certified Public Accountants in Accordance with OMB Circular A-133. Blood Systems, Inc. and Affiliates. Report of Independent Certified Public Accountants in Accordance with OMB Circular A-133 Blood Systems, Inc. and Affiliates December 31, 2014 Contents Report of Independent Certified Public Accountants

More information

Autoimmunity and immunemediated. FOCiS. Lecture outline

Autoimmunity and immunemediated. FOCiS. Lecture outline 1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic

More information

HLA Class I-Restricted Cytotoxic T-Cell Epitopes of the Respiratory Syncytial Virus Fusion Protein

HLA Class I-Restricted Cytotoxic T-Cell Epitopes of the Respiratory Syncytial Virus Fusion Protein JOURNAL OF VIROLOGY, Nov. 2000, p. 10240 10244 Vol. 74, No. 21 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. HLA Class I-Restricted Cytotoxic T-Cell Epitopes

More information

Breakthroughs and Big Questions: AIDS vaccine research in 2014

Breakthroughs and Big Questions: AIDS vaccine research in 2014 Breakthroughs and Big Questions: AIDS vaccine research in 2014 Mary A. Marovich Director, Vaccine Research Program Division of AIDS NIAID/NIH May 19, 2014 1 Future of HIV-1 vaccines is bright Major breakthroughs

More information

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1 AP BIOLOGY ANIMALS FORM & FUNCTION ACTIVITY #4 NAME DATE HOUR BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES Animals Form & Function Activity #4 page 1 INFLAMMATORY RESPONSE ANTIMICROBIAL

More information

Lisa Y. Armitige, MD, PhD has the following disclosures to make:

Lisa Y. Armitige, MD, PhD has the following disclosures to make: Interferon Gamma Release Assays (IGRAs) Lisa Y. Armitige, MD, PhD May 13, 2015 TB for Pulmonologist Phoenix, AZ March 13, 2015 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following

More information

Molecular Diagnosis of Hepatitis B and Hepatitis D infections

Molecular Diagnosis of Hepatitis B and Hepatitis D infections Molecular Diagnosis of Hepatitis B and Hepatitis D infections Acute infection Detection of HBsAg in serum is a fundamental diagnostic marker of HBV infection HBsAg shows a strong correlation with HBV replication

More information

EFFECTS OF IRON ON THE IMMUNE SYSTEM

EFFECTS OF IRON ON THE IMMUNE SYSTEM EFFECTS OF IRON ON THE IMMUNE SYSTEM Gert Mayer Department of Internal Medicine IV (Nephrology and Hypertension) Medical University Innsbruck Austria Conflicts of interest Research Support: Amgen, Roche,

More information

Immunological studies, fibrosis and oxidative stress

Immunological studies, fibrosis and oxidative stress Pathogenesis of hepatitis C virus (HCV) infection: role of genetic, immunologic and environmental factors in HCV-related liver disease and in symptomfree HCV carriers. Hepatitis C virus (HCV) infection

More information

HBV DNA < monitoring interferon Rx

HBV DNA < monitoring interferon Rx Hepatitis B Virus Suspected acute hepatitis >>Order: Acute Unknown hepatitis screen Suspected chronic hepatitis >>Order: Chronic unknown hepatitis screen Acute HBV or Delayed Anti HBs response after acute

More information

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 9/8/2015 Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 Stefan Eichmüller, PhD GMP & T Cell Therapy Unit, German Cancer Research Center, Heidelberg, Germany

More information

Liver Disease and Therapy of Hepatitis B Virus Infections

Liver Disease and Therapy of Hepatitis B Virus Infections Liver Disease and Therapy of Hepatitis B Virus Infections University of Adelaide Catherine Scougall Arend Grosse Huey-Chi Low Allison Jilbert Fox Chase Cancer Center Chunxiao Xu Carol Aldrich Sam Litwin

More information

Testing for RA. The Ideal Lab Test. William M. Wason, MD, PhD 9/24/2010. Confusion Abounds

Testing for RA. The Ideal Lab Test. William M. Wason, MD, PhD 9/24/2010. Confusion Abounds Confusion Abounds Rheumatoid arthritis: ulnar deviation and muscle artrophy, hands Poor sensitivity and specificity Hepatitis C causes lots of false + tests Changing technology in how tests are done Historic

More information

Cell Bank Safety Testing for Cellular Therapeutics. Christopher A Bravery

Cell Bank Safety Testing for Cellular Therapeutics. Christopher A Bravery Cell Bank Safety Testing for Cellular Therapeutics Christopher A Bravery cbravery@advbiols.com 1 Introduction Definitions used in this talk Cellular therapeutics (CTP) EU: Advanced Therapy Medicinal Products

More information